Marcus Adams earned his BEng and MS in Chemical Engineering from the University of Delaware and Villanova University, respectively. His more than decade at Merck spans the bio-pharmaceutical spectrum and includes experience in pre-clinical PK/PD modeling, product commercialization, in-line technology support, procurement, and vaccine distribution technology development.

Currently, Marcus works as a part of the Digital Proactive Process Analytics team, leveraging Merck’s Big Data Platform in the development of manufacturing information data models, report automation tools, and integrated-systems analysis applications.  His professional interests include effective digital visualization, reproducible research/analysis, and convincing his coworkers of the diverse, flourishing world beyond Microsoft Excel.

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. This site is intended for residents of the United States and its territories. For more information, visit www.merck.com.